Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

by Manali Phadke, Lily L. Remsing Rix, Inna Smalley, Annamarie T. Bryant, Yunting Luo, Harshani R. Lawrence, Braydon J. Schaible, Yian A. Chen, Uwe Rix, Keiran S. M. Smalley
Published 2018-01-01

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model

by Bhaswati Sarcar, Nicholas T. Gimbrone, Gabriela Wright, Lily L. Remsing Rix, Edna R. Gordian, Uwe Rix, Alberto A. Chiappori, Gary W. Reuther, Pedro G. Santiago‐Cardona, Teresita Muñoz‐Antonia, William Douglas Cress
Published 2019-10-01

A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL.

by Uwe Rix, Jacques Colinge, Katharina Blatt, Manuela Gridling, Lily L Remsing Rix, Katja Parapatics, Sabine Cerny-Reiterer, Thomas R Burkard, Ulrich Jäger, Junia V Melo, Keiryn L Bennett, Peter Valent, Giulio Superti-Furga
Published 2013-01-01